Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jun;63(6):2310–2316. doi: 10.1128/iai.63.6.2310-2316.1995

Role of Ca2+ and calmodulin in ehrlichial infection in macrophages.

Y Rikihisa 1, Y Zhang 1, J Park 1
PMCID: PMC173302  PMID: 7768614

Abstract

Replication of Ehrlichia risticii was inhibited in P388D1 cells and murine peritoneal macrophages when a calmodulin antagonist (W-7, chlorpromazine, or trifluoperazine); a Ca2+ channel blocker (verapamil, diltiazem, nifedipine, or flunarizine); an extracellular Ca2+ chelator, EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid]; an inhibitor of intracellular Ca2+ mobilization, TMB-8; or Ca2+ ionophore A23187 was added after internalization of the organism at 3 h postincubation. When intracellular ehrlichiae at their logarithmic stage of growth were treated with these reagents, not only was further proliferation prevented but also there was significant reduction in numbers of intracellular ehrlichiae. These reagents prevented spreading of E. risticii from P388D1 cells to THP-1 cells. None of these reagents prevented binding of [35S]methionine-labeled E. risticii to P388D1 cells, but all of these reagents prevented internalization of [35S]methionine-labeled E. risticii. Protein kinase C inhibitors, H-7 and staurosporin, had no effect. 14CO2 production from L-[14C]glutamine in Percoll-density-gradient-purified E. risticii was inhibited by A23187 but not by W-7 or verapamil, suggesting that Ca2+ but not calmodulin directly regulates ehrlichials glutamine oxidation. Pretreatment of E. risticii with W-7 or verapamil did not reduce its infectivity. These results indicate that calmodulin and Ca2+ are essential for ehrlichial internalization, replication, and spreading in macrophages but are not essential for binding.

Full Text

The Full Text of this article is available as a PDF (286.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnewall R. E., Rikihisa Y. Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun. 1994 Nov;62(11):4804–4810. doi: 10.1128/iai.62.11.4804-4810.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baynes R., Bukofzer G., Bothwell T., Bezwoda W., Macfarlane B. Transferrin receptors and transferrin iron uptake by cultured human blood monocytes. Eur J Cell Biol. 1987 Jun;43(3):372–376. [PubMed] [Google Scholar]
  3. Brand M. D., Felber S. M. The intracellular calcium antagonist TMB-8 [8-(NN-diethylamino)octyl-3,4,5-trimethoxybenzoate] inhibits mitochondrial ATP production in rat thymocytes. Biochem J. 1984 Dec 15;224(3):1027–1030. doi: 10.1042/bj2241027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buchmüller-Rouiller Y., Corradin S. B., Mauël J. Macrophage activation for intracellular killing as induced by a Ca2+ ionophore. Dependence on L-arginine-derived nitrogen oxidation products. Biochem J. 1992 Jun 1;284(Pt 2):387–392. doi: 10.1042/bj2840387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ceccarelli B., Hurlbut W. P. Ca2+-dependent recycling of synaptic vesicles at the frog neuromuscular junction. J Cell Biol. 1980 Oct;87(1):297–303. doi: 10.1083/jcb.87.1.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chiou C. Y., Malagodi M. H. Studies on the mechanism of action of a new Ca-2+ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol. 1975 Feb;53(2):279–285. doi: 10.1111/j.1476-5381.1975.tb07359.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Couée I., Tipton K. F. The inhibition of glutamate dehydrogenase by some antipsychotic drugs. Biochem Pharmacol. 1990 Mar 1;39(5):827–832. doi: 10.1016/0006-2952(90)90196-r. [DOI] [PubMed] [Google Scholar]
  8. Fox R., Markham A., Morgan R. Effect of calcium-modifying drugs on glutamate dehydrogenase and isocitrate dehydrogenase activity. Biochem Soc Trans. 1990 Apr;18(2):319–320. doi: 10.1042/bst0180319. [DOI] [PubMed] [Google Scholar]
  9. Grasso J. A., Bruno M., Yates A. A., Wei L. T., Epstein P. M. Calmodulin dependence of transferrin receptor recycling in rat reticulocytes. Biochem J. 1990 Feb 15;266(1):261–272. doi: 10.1042/bj2660261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
  11. Hansford R. G. Relation between mitochondrial calcium transport and control of energy metabolism. Rev Physiol Biochem Pharmacol. 1985;102:1–72. doi: 10.1007/BFb0034084. [DOI] [PubMed] [Google Scholar]
  12. Hauschildt S., Lückhoff A., Mülsch A., Kohler J., Bessler W., Busse R. Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+. Biochem J. 1990 Sep 1;270(2):351–356. doi: 10.1042/bj2700351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hidaka H., Sasaki Y., Tanaka T., Endo T., Ohno S., Fujii Y., Nagata T. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4354–4357. doi: 10.1073/pnas.78.7.4354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Janis R. A., Triggle D. J. New developments in Ca2+ channel antagonists. J Med Chem. 1983 Jun;26(6):775–785. doi: 10.1021/jm00360a001. [DOI] [PubMed] [Google Scholar]
  15. Kawamoto S., Hidaka H. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun. 1984 Nov 30;125(1):258–264. doi: 10.1016/s0006-291x(84)80362-9. [DOI] [PubMed] [Google Scholar]
  16. Levitzki A., Willingham M., Pastan I. Evidence for participation of transglutaminase in receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 1980 May;77(5):2706–2710. doi: 10.1073/pnas.77.5.2706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lisanti M. P., Shapiro L. S., Moskowitz N., Hua E. L., Puszkin S., Schook W. Isolation and preliminary characterization of clathrin-associated proteins. Eur J Biochem. 1982 Jul;125(2):463–470. doi: 10.1111/j.1432-1033.1982.tb06706.x. [DOI] [PubMed] [Google Scholar]
  18. McCormack J. G., Denton R. M. Influence of calcium ions on mammalian intramitochondrial dehydrogenases. Methods Enzymol. 1989;174:95–118. doi: 10.1016/0076-6879(89)74013-1. [DOI] [PubMed] [Google Scholar]
  19. Means A. R., Tash J. S., Chafouleas J. G. Physiological implications of the presence, distribution, and regulation of calmodulin in eukaryotic cells. Physiol Rev. 1982 Jan;62(1):1–39. doi: 10.1152/physrev.1982.62.1.1. [DOI] [PubMed] [Google Scholar]
  20. Messick J. B., Rikihisa Y. Characterization of Ehrlichia risticii binding, internalization, and proliferation in host cells by flow cytometry. Infect Immun. 1993 Sep;61(9):3803–3810. doi: 10.1128/iai.61.9.3803-3810.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Park J., Rikihisa Y. Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A. Infect Immun. 1991 Oct;59(10):3418–3423. doi: 10.1128/iai.59.10.3418-3423.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Park J., Rikihisa Y. L-arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon. Infect Immun. 1992 Sep;60(9):3504–3508. doi: 10.1128/iai.60.9.3504-3508.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rasmussen H. The calcium messenger system (1). N Engl J Med. 1986 Apr 24;314(17):1094–1101. doi: 10.1056/NEJM198604243141707. [DOI] [PubMed] [Google Scholar]
  24. Rikihisa Y. The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev. 1991 Jul;4(3):286–308. doi: 10.1128/cmr.4.3.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rikihisa Y., Zhang Y., Park J. Inhibition of infection of macrophages with Ehrlichia risticii by cytochalasins, monodansylcadaverine, and taxol. Infect Immun. 1994 Nov;62(11):5126–5132. doi: 10.1128/iai.62.11.5126-5132.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Safayhi H., Kühn M., Koopmann I., Ammon H. P. CGS 9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):8–13. doi: 10.1007/BF00165119. [DOI] [PubMed] [Google Scholar]
  27. Salisbury J. L., Condeelis J. S., Maihle N. J., Satir P. Calmodulin localization during capping and receptor-mediated endocytosis. Nature. 1981 Nov 12;294(5837):163–166. doi: 10.1038/294163a0. [DOI] [PubMed] [Google Scholar]
  28. Salisbury J. L., Condeelis J. S., Satir P. Receptor-mediated endocytosis: machinery and regulation of the clathrin-coated vesicle pathway. Int Rev Exp Pathol. 1983;24:1–62. [PubMed] [Google Scholar]
  29. Salisbury J. L., Condeelis J. S., Satir P. Role of coated vesicles, microfilaments, and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid cells. J Cell Biol. 1980 Oct;87(1):132–141. doi: 10.1083/jcb.87.1.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shainkin-Kestenbaum R., Winikoff Y., Kol R., Chaimovitz C., Sarov I. Inhibition of growth of Chlamydia trachomatis by the calcium antagonist verapamil. J Gen Microbiol. 1989 Jun;135(6):1619–1623. doi: 10.1099/00221287-135-6-1619. [DOI] [PubMed] [Google Scholar]
  31. Sneddon J. M., Wenman W. M. The effect of ions on the adhesion and internalization of Chlamydia trachomatis by HeLa cells. Can J Microbiol. 1985 Apr;31(4):371–374. doi: 10.1139/m85-071. [DOI] [PubMed] [Google Scholar]
  32. Söderlund G., Kihlström E. Effect of methylamine and monodansylcadaverine on the susceptibility of McCoy cells to Chlamydia trachomatis infection. Infect Immun. 1983 May;40(2):534–541. doi: 10.1128/iai.40.2.534-541.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun. 1986 Mar 13;135(2):397–402. doi: 10.1016/0006-291x(86)90008-2. [DOI] [PubMed] [Google Scholar]
  34. Triggle D. J., Janis R. A. Calcium channel ligands. Annu Rev Pharmacol Toxicol. 1987;27:347–369. doi: 10.1146/annurev.pa.27.040187.002023. [DOI] [PubMed] [Google Scholar]
  35. Vincent R., Nadeau D. A micromethod for the quantitation of cellular proteins in Percoll with the Coomassie brilliant blue dye-binding assay. Anal Biochem. 1983 Dec;135(2):355–362. doi: 10.1016/0003-2697(83)90696-6. [DOI] [PubMed] [Google Scholar]
  36. Ward M. E., Salari H. Control mechanisms governing the infectivity of Chlamydia trachomatis for hela cells: modulation by cyclic nucleotides, prostaglandins and calcium. J Gen Microbiol. 1982 Mar;128(3):639–650. doi: 10.1099/00221287-128-3-639. [DOI] [PubMed] [Google Scholar]
  37. Weiel J. E., Adams D. O., Hamilton T. A. Biochemical models of gamma-interferon action: altered expression of transferrin receptors on murine peritoneal macrophages after treatment in vitro with PMA or A23187. J Immunol. 1985 Jan;134(1):293–298. [PubMed] [Google Scholar]
  38. Weiss B., Prozialeck W. C., Wallace T. L. Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. Biochem Pharmacol. 1982 Jul 1;31(13):2217–2226. doi: 10.1016/0006-2952(82)90104-6. [DOI] [PubMed] [Google Scholar]
  39. Weiss E., Dasch G. A., Kang Y. H., Westfall H. N. Substrate utilization by Ehrlichia sennetsu and Ehrlichia risticii separated from host constituents by renografin gradient centrifugation. J Bacteriol. 1988 Nov;170(11):5012–5017. doi: 10.1128/jb.170.11.5012-5017.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiss E., Williams J. C., Dasch G. A., Kang Y. H. Energy metabolism of monocytic Ehrlichia. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1674–1678. doi: 10.1073/pnas.86.5.1674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wright B., Zeidman I., Greig R., Poste G. Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists. Cell Immunol. 1985 Oct 1;95(1):46–53. doi: 10.1016/0008-8749(85)90293-x. [DOI] [PubMed] [Google Scholar]
  42. Zhang S. P., Prozialeck W. C., Weiss B. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts. Mol Pharmacol. 1990 Nov;38(5):698–704. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES